893 related articles for article (PubMed ID: 2899772)
1. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):3A-13A. PubMed ID: 2903874
[TBL] [Abstract][Full Text] [Related]
3. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
4. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
[TBL] [Abstract][Full Text] [Related]
5. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R
BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981
[TBL] [Abstract][Full Text] [Related]
6. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
7. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
[TBL] [Abstract][Full Text] [Related]
8. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Lancet; 1986 Jul; 2(8498):57-66. PubMed ID: 2873379
[TBL] [Abstract][Full Text] [Related]
9. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.
Lancet; 1993 Sep; 342(8874):767-72. PubMed ID: 8103875
[TBL] [Abstract][Full Text] [Related]
10. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.
Lancet; 1997 Jun; 349(9066):1641-9. PubMed ID: 9186381
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
Collins R; MacMahon S; Flather M; Baigent C; Remvig L; Mortensen S; Appleby P; Godwin J; Yusuf S; Peto R
BMJ; 1996 Sep; 313(7058):652-9. PubMed ID: 8811758
[TBL] [Abstract][Full Text] [Related]
12. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.
Goa KL; Henwood JM; Stolz JF; Langley MS; Clissold SP
Drugs; 1990 May; 39(5):693-719. PubMed ID: 2191849
[TBL] [Abstract][Full Text] [Related]
13. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321
[TBL] [Abstract][Full Text] [Related]
14. [Systemic thrombolysis using streptokinase. Experiences at the Civic Hospital of Lugano in the framework of the ISIS-2 study].
Moccetti T; Rezzonico M; Clara F; Riva A; Tanzi F; Genoni M; Malacrida R
Schweiz Med Wochenschr; 1988 Nov; 118(46):1702-5. PubMed ID: 3212423
[TBL] [Abstract][Full Text] [Related]
15. Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.
Battershill PE; Benfield P; Goa KL
Drugs Aging; 1994 Jan; 4(1):63-86. PubMed ID: 8130384
[TBL] [Abstract][Full Text] [Related]
16. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
Van de Werf F; Arnold AE
BMJ; 1988 Nov; 297(6660):1374-9. PubMed ID: 3146370
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group.
Lancet; 1995 Dec; 346(8989):1509-14. PubMed ID: 7491044
[TBL] [Abstract][Full Text] [Related]
18. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
19. [ISIS-2, an international study of survival after a heart infarct: the power of large numbers?].
Koster RW
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):338-40. PubMed ID: 2648174
[No Abstract] [Full Text] [Related]
20. [Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2].
Madsen JK; Pedersen F; Amtoft A; Deding A; Grande P; Hansen JN; Hilden M; Hornum I; Jensen T; Lindskov J
Ugeskr Laeger; 1989 Oct; 151(40):2565-9. PubMed ID: 2683281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
